Pfizer Announces DUAVEE® (conjugated estrogens/bazedoxifene), an Estrogen-Based Menopause Hormone Therapy, Now Back in Stock with Improved Packaging
NEW YORK, June 5, 2023 – Pfizer Inc. (NYSE: PFE) today announced that DUAVEE® (conjugated estrogens/bazedoxifene), an estrogen-based menopause hormone therapy, is now back in stock in the United States, with improved packaging, following a voluntary recall. The recall was due to an issue with the packaging and was not based on any efficacy or safety concerns with the product itself.
U.S. Travel Update: Lyme Disease in Europe
Prior to the COVID-19 pandemic, Americans made more than 38 million trips to Europe in a single year. Now that official agencies have declared an end to the COVID-19 public health emergency (PHE) and travel restrictions have been lifted for the majority of the world, exploring Europe is once again possible.
Pfizer to Share Oncology Advancements at ASCO Annual Meeting
Cancer remains one of the greatest health challenges of our lifetime. It steals precious moments and robs us of our passions and dreams. But at Pfizer, we're up for the challenge. Because while cancer never rests, neither do we.
Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with the European Commission
NEW YORK and MAINZ, GERMANY, MAY 26, 2023 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have reached an agreement with the European Commission (EC) to amend their existing contract to deliver COVID-19 vaccines to the European Union.
Research!America Offers $200k Discovery | Innovation | Health Prize for COVID-19 Innovator
Breakthroughs like the COVID-19 vaccine don’t just materialize out of nowhere. They’re borne from bold visions, buoyed by constant collaboration, and realized only through persistence, perseverance, and hard work.
Events in NYC and Italy Spotlight Disability Inclusion
When you’re in the business of breakthroughs, you want to work with the best. While great talent comes from all backgrounds, they don’t all have the same access to professional opportunities or to environments where they’ll thrive.
Global and U.S. Agencies Declare End of COVID-19 Emergency
On May 5, more than three years since COVID-19 was designated as a pandemic, the World Health Organization (WHO) declared an end to the global Public Health Emergency (PHE) for COVID-19.
Pfizer Sets New Ambition: Changing a Billion Lives a Year by 2027
In April, Pfizer CEO Albert Bourla stood centerstage at Pfizer’s brand-new Hudson Yards headquarters in New York, NY and unveiled the company’s brand-new “purpose blueprint.”